共 50 条
- [1] In vivo detection of caspase activity in patients with chronic hepatitis C as a novel biomarker of disease severityHEPATOLOGY, 2007, 46 (04) : 850A - 850AElgouhari, Hesham M.Zein, Nizar N.Hanouneh, Ibrahim A.Yerian, Lisa M.Lopez, RocioFeldstein, Ariel E.
- [2] MicroRNA as novel biomarker for disease severity evaluation and therapeutic target in NAFLDJOURNAL OF HEPATOLOGY, 2023, 78 : S798 - S799Lee, YoonseokLee, Young-SunKim, Ji HoonChoi, EunhoKim, Tae HyungYim, Sun YoungJung, Young KulSeo, Yeon SeokYeon, Jong EunByun, Kwan Soo
- [3] Detection of caspase activity in the blood of patients with nonalcoholic fatty liver disease as a novel biomarker of disease severityGASTROENTEROLOGY, 2006, 130 (04) : A749 - A749Wieckowska, AnnaZein, NizarYerian, LisaLopez, Ana R.Feldstein, Ariel E.
- [4] Detection of caspase activity in the plasma of patients with various liver diseases as a novel biomarker of hepatic fibrosisAMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S247 - S247Elgouhari, Hesham M.Zein, Nizar N.Yerian, LisaHanouneh, Ibrahim A.Lopez, RocioFeldestein, Ariel E.
- [5] Machine learning algorithms identify novel biomarker combinations for NAFLDJOURNAL OF HEPATOLOGY, 2022, 77 : S74 - S74Lee, JennyWestphal, MaxVali, YasamanChen, YuAlexander, LeighBoursier, JeromeAnstee, QuentinZwinderman, AeilkoBossuyt, Patrick
- [6] EpCAM+CD133+MICROVESICLES: NOVEL BIOMARKER IN NAFLDHEPATOLOGY, 2022, 76 : S99 - S100Munoz-Hernandez, RocioGato-Zambrano, SheilaAller, RocioBlazquez-Lopez, ElenaGallego, JavierMoran, LauraJavier Cubero, FranciscoVaquero, JavierBanares, RafaelRojas, AngelaGil-Gomez, AntonioGallego-Duran, RocioMontero-Vallejo, RocioMaya, DouglasGarcia-Fernandez, VanessaDel Carmen Rico, MariaAmpuero Herrojo, JavierRomero-Gomez, Manuel
- [7] Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLDLIVER INTERNATIONAL, 2021, 41 (03) : 505 - 514Kimura, TakefumiTanaka, NaokiFujimori, NaoyukiYamazaki, TomooKatsuyama, TakahitoIwashita, YuichiPham, JonathanJoshita, SatoruPydi, Sai P.Umemura, Takeji
- [8] LIPOPROTEIN(A) LEVELS IN NAFLD PATIENTS: A NOVEL BIOMARKER TO PREDICT HEPATIC FIBROSISHEPATOLOGY, 2021, 74 : 1114A - 1114AMeroni, MaricaLongo, MiriamLombardi, RosaPaolini, ErikaMacchi, ChiaraCorsini, AlbertoSirtori, CesareFracanzani, Anna LudovicaRuscica, MassimilianoDongiovanni, Paola
- [9] Novel high-throughput applications for NAFLD diagnostics and biomarker discoveryHEPATOMA RESEARCH, 2021, 7Giraudi, Pablo J.Stephenson, Adam M.Tiribelli, ClaudioRosso, Natalia
- [10] Circulating Fibroblast Activation Protein activity as a liver fibrosis biomarker in NAFLDJOURNAL OF HEPATOLOGY, 2017, 66 (01) : S666 - S667Zhang, H. E.Brewer, K.Jeffrey, G. P.Twigg, S. M.McCaughan, G. W.Williams, K. H.Adams, L. A.Gorrell, M. D.